These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study. Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581 [TBL] [Abstract][Full Text] [Related]
8. Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Contin M; Riva R; Albani F; Avoni P; Baruzzi A Ther Drug Monit; 2002 Jun; 24(3):332-7. PubMed ID: 12021622 [TBL] [Abstract][Full Text] [Related]
9. Topiramate: a review of its use in the treatment of epilepsy. Lyseng-Williamson KA; Yang LP Drugs; 2007; 67(15):2231-56. PubMed ID: 17927286 [TBL] [Abstract][Full Text] [Related]
10. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting. Guerrini R; Carpay J; Groselj J; van Oene J; Schreiner A; Lahaye M; Schwalen S; Seizure; 2005 Sep; 14(6):371-80. PubMed ID: 15961326 [TBL] [Abstract][Full Text] [Related]
11. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy. Arroyo S; Dodson WE; Privitera MD; Glauser TA; Naritoku DK; Dlugos DJ; Wang S; Schwabe SK; Twyman RE; Acta Neurol Scand; 2005 Oct; 112(4):214-22. PubMed ID: 16146489 [TBL] [Abstract][Full Text] [Related]
12. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy. Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B; Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865 [TBL] [Abstract][Full Text] [Related]
13. Topiramate in the long-term management of refractory epilepsy. Topiramate YOL Study Group. Abou-Khalil B Epilepsia; 2000; 41(S1):72-6. PubMed ID: 10768305 [TBL] [Abstract][Full Text] [Related]
18. Topiramate slow dose titration: improved efficacy and tolerability. Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117 [TBL] [Abstract][Full Text] [Related]
19. A study of topiramate pharmacokinetics and tolerability in children with epilepsy. Rosenfeld WE; Doose DR; Walker SA; Baldassarre JS; Reife RA Pediatr Neurol; 1999 May; 20(5):339-44. PubMed ID: 10371378 [TBL] [Abstract][Full Text] [Related]
20. Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison. Levisohn PM; Holland KD Epilepsy Behav; 2007 Jun; 10(4):547-52. PubMed ID: 17482520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]